16800 West Twelve Mile Road
Suite 201, Southfield, MI 48076

Uncategorized

Therapeutic Discovery Tax Grants Awarded

HPRL Awarded Qualifying Therapeutic Discovery Tax Grants for two of its on-going research programs; “Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia” and “Discovery and Development of Anti-Diabetic Drugs.”

2009 Lasker Award

Dr. Charles Sawyers shares the 2009 Lasker Award for his work elucidating the mechanism of drug-resistance in Chronic Myelogenous Leukemia (CML).

Awarded SBIR Phase I Grant

HPRL Awarded Phase I Small Business Innovation Research (SBIR) Grant for “Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia (CML).”

Awarded SBIR Phase II Grant

HPRL Awarded Phase II Small Business Innovation Research (SBIR) Grant for the “Discovery and Development of Anti-Diabetic Drugs.”